Search - tctmd.com

Displaying 1 - 20 of 81

Sort: Relevancy | Date

News Conference News ACC 2026

Two Neutral IVUS Trials in Complex PCI—and One Positive—Spark Debate

Todd Neale

April 02, 2026

News Conference News ACC 2026

Olezarsen Doesn’t Lower Plaque Volume: Essence-TIMI 73b

Yael L. Maxwell

April 01, 2026

Presentation ACC 2026

IVUS–Guided versus Angiography-Guided PCI in Unprotected Left Main Disease

Presenter: Luca Testa

March 30, 2026

Presentation ACC 2026

IVUS or angiography guidance for PCI in complex coronary bifurcation lesions: The DKCRUSH VIII Trial

Presenter: Shao-Liang Chen

March 30, 2026

News Conference News ACC 2026

ORBITA-CTO: PCI Reduces Angina Symptoms in Sham-Controlled Trial

Michael O'Riordan

March 29, 2026

News Conference News ACC 2026

Noninvasive FFR Measures Match Wire-Based Assessment: ALL RISE and FAST III

L.A. McKeown

March 29, 2026

Presentation ACC 2026

Deferral of PCI in Patients Undergoing TAVI (PRO-TAVI): an Investigator-Initiated, Multicenter, Open-Label, Noninferiority, Randomized Controlled Trial

Presenter: Michiel Voskuil

March 29, 2026

Presentation ACC 2026

Fractional Flow Reserve or 3D-Quantitative-Coronary-Angiography Based Vessel-FFR guided revascularization: the FAST III Trial

Presenter: Joost Daemen

March 29, 2026

News Conference News ACC 2026

What’s Going to Be Hot at ACC 2026

Michael O'Riordan

March 20, 2026

News Conference News ACC 2025

Cardiologists Plot Next Moves After New Board Rejected

Yael L. Maxwell

April 11, 2025

News Conference News ACC 2025

PCI Rebounds at 5 Years to Mostly Match CABG: Final FAME 3 Data

Caitlin E. Cox

March 31, 2025

Presentation ACC 2025

Comparison of angiography-derived fractional flow reserve-guided and intravascular ultrasound-guided PCI strategies (FLAVOUR II)

Presenter: Jian’an Wang

March 30, 2025

News Conference News ACC 2025

WARRIOR: No Clear Answers on How to Best Treat INOCA

Yael L. Maxwell

March 29, 2025

News Opinion Editor's Corner ACC 2025

What’s Going to Be Hot at ACC 2025?

Michael O'Riordan

March 26, 2025

News Conference News ACC 2024

TARGET BP 1: Alcohol-Based RDN Promises Single Treatment for Resistant BP

L.A. McKeown

April 16, 2024

News Conference News ACC 2024

Triglyceride-Lowering Therapies Provide Favorable Outcomes in Early Testing

Michael O'Riordan

April 12, 2024

News Conference News ACC 2024

Telemedicine Strategy After MI Scores a Win in TELE-ACS

Caitlin E. Cox

April 12, 2024

News Conference News ACC 2024

IVUS Benefits Patients Receiving DCBs for Fem-Pop Disease

Caitlin E. Cox

April 10, 2024

Presentation ACC 2024

Comparison of IVUS-guided vs. Angiography-guided Angioplasty for the Outcomes of DCB in the Treatment of Femoropopliteal Artery Disease

Presenter: Young-Guk Ko

April 08, 2024

News Conference News ACC 2024

Another Beta-blocker Blow: REDUCE-AMI Confirms No Benefit After Acute MI

Michael O'Riordan

April 07, 2024

Advertisement

Two Neutral IVUS Trials in Complex PCI—and One Positive—Spark Debate

Olezarsen Doesn’t Lower Plaque Volume: Essence-TIMI 73b

IVUS–Guided versus Angiography-Guided PCI in Unprotected Left Main Disease

IVUS or angiography guidance for PCI in complex coronary bifurcation lesions: The DKCRUSH VIII Trial

ORBITA-CTO: PCI Reduces Angina Symptoms in Sham-Controlled Trial

Noninvasive FFR Measures Match Wire-Based Assessment: ALL RISE and FAST III

Deferral of PCI in Patients Undergoing TAVI (PRO-TAVI): an Investigator-Initiated, Multicenter, Open-Label, Noninferiority, Randomized Controlled Trial

Fractional Flow Reserve or 3D-Quantitative-Coronary-Angiography Based Vessel-FFR guided revascularization: the FAST III Trial

What’s Going to Be Hot at ACC 2026

Cardiologists Plot Next Moves After New Board Rejected

PCI Rebounds at 5 Years to Mostly Match CABG: Final FAME 3 Data

Comparison of angiography-derived fractional flow reserve-guided and intravascular ultrasound-guided PCI strategies (FLAVOUR II)

WARRIOR: No Clear Answers on How to Best Treat INOCA

What’s Going to Be Hot at ACC 2025?

TARGET BP 1: Alcohol-Based RDN Promises Single Treatment for Resistant BP

Triglyceride-Lowering Therapies Provide Favorable Outcomes in Early Testing

Telemedicine Strategy After MI Scores a Win in TELE-ACS

IVUS Benefits Patients Receiving DCBs for Fem-Pop Disease

Comparison of IVUS-guided vs. Angiography-guided Angioplasty for the Outcomes of DCB in the Treatment of Femoropopliteal Artery Disease

Another Beta-blocker Blow: REDUCE-AMI Confirms No Benefit After Acute MI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content